(Q47414654)

English

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

scientific article published on January 1, 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML (English)

1 reference

10.1038/SJ.LEU.2403187

https://api.crossref.org/works/10.1038/SJ.LEU.2403187

26 March 2024

therapy-related acute myeloid leukemia

0 references

0 references

1 reference

based on heuristic

inferred from title

chromosome abnormality

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586477

26 March 2024

1 reference

10.1038/SJ.LEU.2403187

https://api.crossref.org/works/10.1038/SJ.LEU.2403187

26 March 2024

author name string

C. Schoch

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586477

26 March 2024

W. Kern

2

0000-0002-6452-2874

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586477

26 March 2024

S. Schnittger

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586477

26 March 2024

W. Hiddemann

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586477

26 March 2024

T. Haferlach

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14586477

26 March 2024

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14586477

26 March 2024

publication date

1 January 2004

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

full work available at URL

https://www.nature.com/articles/2403187.pdf

Portable Document Format

1 reference

10.1038/SJ.LEU.2403187

https://api.crossref.org/works/10.1038/SJ.LEU.2403187

26 March 2024

https://www.nature.com/articles/2403187

1 reference

10.1038/SJ.LEU.2403187

https://api.crossref.org/works/10.1038/SJ.LEU.2403187

26 March 2024

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

18

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

120-125

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

1

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403187

0 references

Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported i

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Two different classes of therapy-related and de-novo acute myeloid leukemia?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Topoisomerase II inhibitors induce DNA double-strand breaks at a specific site within the AML1 locus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Comparison of chromosome banding analysis, interphase- and hypermetaphase-FISH, qualitative and quantitative PCR for diagnosis and for follow-up in chronic myeloid leukemia: a study on 350 cases.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Karyotype and age in acute myeloid leukemia. Are they linked?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

AML associated with previous cytotoxic therapy, MDS or myeloproliferative disorders: results from the MRC's 9th AML trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Clinicobiological features and outcome of acute promyelocytic leukemia occurring as a second tumor: the GIMEMA experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

21 January 2018

Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytogenetics of secondary myelodysplasia (sMDS) and acute nonlymphocytic leukemia (sANLL)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Balanced chromosome aberrations in leukemias following chemotherapy with DNA-topoisomerase II inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary leukemias induced by topoisomerase-targeted drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary acute leukemia and myelodysplastic syndrome with 11q23 abnormalities. EU Concerted Action 11q23 Workshop

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy-related acute promyelocytic leukemia: a report on 16 cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive chemotherapy with idarubicin, cytosine arabinoside, and granulocyte colony-stimulating factor (G-CSF) in patients with secondary and therapy-related acute myelogenous leukemia. Club de Réflexion en Hématologie

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

Dependence of age-specific incidence of acute myeloid leukemia on karyotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

A single-center population-based consecutive series of 1500 cytogenetically investigated adult hematological malignancies: karyotypic features in relation to morphology, age and gender

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403187

7 January 2021

based on heuristic

inferred from DOI database lookup

10

84

937

author name string

G Leone

publication date

1999

1 reference

10.1038/SJ.LEU.2403187

https://api.crossref.org/works/10.1038/SJ.LEU.2403187

26 March 2024

20

83

483

author name string

MK Andersen

publication date

1998

1 reference

10.1038/SJ.LEU.2403187

https://api.crossref.org/works/10.1038/SJ.LEU.2403187

26 March 2024

Identifiers

10.1038/SJ.LEU.2403187

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

1 reference

Europe PubMed Central

15 January 2018

http://europepmc.org/abstract/MED/14586477

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47414654&oldid=2113546349"